Biologics work by targeting proteins that cause inflammation in ulcerative colitis. As a result, certain biologics help ...

FDA approves Eli Lilly's Omvoh for Crohn's disease, showing strong Phase 3 results in clinical remission and intestinal ...

For patients with ulcerative colitis, upadacitinib is associated with improved disease-specific outcomes compared with tofacitinib.

Regular communication with them throughout your treatment is key. The best medicine for ulcerative colitis depends on several factors, such as the severity of the disease and its location.

For patients with ulcerative colitis, upadacitinib is associated with improved disease-specific outcomes at 12 months compared with tofacitinib, according to a study published in the December ...

CU-06 is under clinical development by Curacle and currently in Phase I for Ulcerative Colitis. According to GlobalData, Phase I drugs for Ulcerative Colitis have an 82% phase transition success rate ...

Crohn's disease and ulcerative colitis are idiopathic ... important subsets of patients for whom the natural history of disease and response to treatment are predictable. The most widely held ...

Unfortunately, ulcerative colitis can occur in anyone, including pregnant women. But that does not mean you do not plan for a family. With proper management and treatment, women can experience a ...